Carboplatin and sodium butyrate, separate - Yes, but combined - Never

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 1, 2013, Pages 153-161

  Gurtowska, Natalia ^a   Kloskowski, Tomasz ^a   Olkowska, Joanna ^a   Bajek, Anna ^a   Dȩbski, Robert ^a   Zielaskowska, Jowita ^a   Drewa, Tomasz ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

Author keywords

Cancer stem cells; Carboplatin; Melanoma; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CARBOPLATIN; CD133 ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SELECTION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; G1 PHASE CELL CYCLE CHECKPOINT; IN VITRO STUDY; LC 50; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; S PHASE CELL CYCLE CHECKPOINT; SURVIVAL RATE;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BUTYRATES; CARBOPLATIN; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GLYCOPROTEINS; HISTONE DEACETYLASE INHIBITORS; IMMUNOMAGNETIC SEPARATION; MELANOMA, EXPERIMENTAL; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872931445     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. DiVito K.A., Berger A.J., Camp R.L., Dolled-Filhart M., Rimm D.L., Kluger H.M.: Cancer Res. 64, 8773 (2004).
2. Kordek R., Jassem J., Krzakowski M., Jeziorski A.: in Oncology - handbook for students and physicians. Cancer chemotherapy and hormonal therapy. Melanoma. pp. 60-67, 196-200, Via Medica, Gdańsk 2004.
3. Sato K., Kusaka Y., Okada K.: Ind. Health 39, 21 (2001).
4. Woźniak K., Błasik J.: Acta Biochim. Pol. 49, 583 (2002).
5. Go R.S., Adjei A.A.: J. Clin. Oncol. 17, 409 (1999).
6. Ogawa H., Rafiee P., Fisher P.J., Johnson N.A., Otterson M.F., Binion D.G.: Biochem. Biophys. Res. Commun. 309, 512 (2003).
7. Shao Y., Gao Z., Marks P.A., Jiang X.: Proc. Natl. Acad. Sci. USA 101, 18030 (2004).
8. Bi G., Jiang G.: Cell Mol. Immunol. 3, 285 (2006).
9. Boyle G.M., Martyn A.C., Parsons P.G.: Pigment Cell Res. 18, 160 (2005).
10. Louis M., Rosato R.R., Brault L., Osbild S., Battaglia E., Yang X.H., Grant S., Bagrel D.: Int. J. Oncol. 25, 1701 (2004).
11. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., Tahan S.R.: Mod. Pathol. 20, 102 (2007).
12. Nohara K., Yokoyama Y., Kano K.: Kobe J. Med. Sci. 53, 265 (2007).
13. Monzani E., Facchetti F., Galmozzi E., Corsini E., Benetti A., Cavazzin C. et al.: Eur. J. Cancer 43, 935 (2007).
14. Reya T., Morrison S.J., Clarke M.F., Weissman I.L.: Nature 414, 105 (2001).
15. Sabatino M., Stroncek D.F., Klein H., Marincola F.M., Wang E.: Cancer Lett. 279, 119 (2009).
16. Chudonovsky Y., Khavari P.A., Adams A.E.: J. Clin. Invest. 115, 813 (2005).
17. Fang A., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S. et al.: Cancer Res. 65, 9328 (2005).
18. Grossman D., Altieri D.C.: Cancer Metast. Rev. 20, 3 (2001).
19. Demary K., Wong L., Spanjaard R.A.: Cancer Lett. 163, 103 (2001).
20. Dou J., Wen P., Hu W., Li Y., Wu Y., Liu C. et al.: Cell Biol. Int. 33, 807 (2009).
21. Tirino V., Desiderio V., D'Aquino R., De Francesco F., Pirozzi G., Galderisi U. et al.: PLoS ONE. Doi:10.1371/journal.pone.0003469 (2008).
22. Singh S.K., Hawkins C., Clarke I.D. et al.: Nature 432, 396 (2004).
23. Dou J., Pan M., Wen P., Li Y., Tang Q., Chu L. et al.: Cell. Mol. Immunol. 4, 467 (2007).
24. de Haan J.B., Gevers W., Parker M.I.: Cancer Res. 46, 713 (1986).
25. Kurita-Ochiai T., Hashizume T., Yonezawa H., Ochiai K., Yamamoto M.: Immunol. Med. Microbiol. 47, 67 (2006).
26. Giermasz A., Makowski M., Nowis D., Jalili A., Maj M., Da̧browska A.: Oncol. Rep. 9, 199 (2002).
27. Sato T., Suzuki M., Sato Y., Echigo S., Rikiishi H.: Int. J. Oncol. 28, 1233 (2006).
28. Facchetti F., Previdi S., Ballarini M., Minucci S., Perego P., Porta C.A.: Apoptosis 9, 573 (2004).
29. Huang Y., Sadée W.: Cancer Lett. 239, 168 (2006).
30. Munshi A., Kurland J.F., Naishikawa T.: Clin. Cancer Res. 11, 4912 (2005).
31. Bandyopadhyay D., Mishra A., Medrano E.E.: Cancer Res. 64, 7706 (2004).
32. Halaban R., Cheng E., Zhang Y., Mandgo C.E., Miglarese M.R.: Oncogene 16, 2489 (1998).
33. Joseph J., Wajapeyee N., Somasundaram K.: Int. J. Cancer. 115, 11 (2005).
34. Wang Y.F., Chen N.S., Chung Y.P., Chang L.H., Chiou Y.H., Chen C.Y.: Mol. Cell Biochem. 285, 51 (2006).
35. Giermasz A., Nowis D., Jalili A., Basak G., Marczak M., Makowski M., Czajka A., Młynarczuk I., Hoser G., Stokłosa T., Lewandowski S., Jakóbisiak M.: Cancer Lett. 164, 143 (2001).
36. Rousseu D., Khochbin S., Gorka C., Lawrence J.J.: Eur. J. Biochem. 2008, 775 (1992).
37. Gill M., Celebi J.: J. Am. Acad. Dermatol. 53, 108 (2005).
38. Houghton A.N., Polsky D.: Cancer Cell 2, 275 (2002).
39. Sang L., Roberts J.M., Coller H.A.: Trends Mol. Med. 16, 17 (2010).
40. Cinatl J. Jr, Kotchetkov R., Blaheta R., Driever P.H., Vogel J.U., Cinatl J.: Int. J. Oncol. 20, 97 (2002).